| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9eec25614c242d77119bef77258568 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2018-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a70e6b684c70cd111dead33e4ae751b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_990c4a1e8c1002a96f9e5a367883b893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5b64240bae81eb17898e130dda23b80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f184fbe68d59baa48528fce80f79503e |
| publicationDate |
2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019101888-A1 |
| titleOfInvention |
Dosage regimen of vidofludimus for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases |
| abstract |
The present invention refers to a 2-({3-fluoro-3'-methoxy-[1,1'-biphenyl]-4- yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid) according to formula (I) and a novel dosage regimen as well as their uses in the treatment of chronic inflammatory and/or autoimmune diseases. The said compound of formula (I) inhibits dihydroorotate dehydrogenase (DHODH), and is known for the treatment and prevention of diseases, in particular their use in diseases where there is an advantage in inhibiting dihydroorotate dehydrogenase (DHODH). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023118576-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3892268-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3900717-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021204985-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022200615-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021214033-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11376232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022214691-A1 |
| priorityDate |
2017-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |